PT Soho Global Health Tbk
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-55.5% vs price
Base Case (Median)
-46.1% vs price
Bull Case (75th pct.)
-4.7% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $242.88 | -79.2% | High (40%) |
| PE Comparable | $1146.30 | -2.0% | Medium (25%) |
| Growth Trajectory DCF | $1357.68 | 16.0% | Medium (20%) |
| Graham Number | $486.85 | -58.4% | Medium (40%) |
| EV/EBITDA | $630.83 | -46.1% | Medium (20%) |
| EV/FCF | $1083.03 | -7.4% | Medium (20%) |
| Earnings Power Value | $553.60 | -52.7% | Medium (50%) |
Based on 7 out of 8 methods, SOHO.JK appears overvalued at the current price of $1170.00. The base case fair value of $630.83 implies 46.1% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.